
About JW Life Science
JW Life Science is a publicly listed company based in Seoul (South Korea) founded in 1994. Intravenous solutions and pharmaceuticals are manufactured for healthcare providers. The company has 328 employees. JW Life Science offers products and services including Intravenous Fluids and Research Services. Its focus areas include Medical Supplies and Consumables and Diversified. Its legal entity is JWμλͺ κ³Όν.
Company details
JW Life Science was founded in 1994 in Seoul, South Korea. Intravenous solutions and a range of pharmaceutical products are manufactured by the company. Research and development activities in related pharmaceutical areas are conducted. Products are supplied to healthcare providers within the medical sector. Operations encompass production, research, and distribution across the pharmaceutical industry.
- Headquarters Seoul, South Korea
- Employees 328
- Stage Public
- SectorsHealthcare
- Website jw-lifescience.co.kr/lifescience/ko/main.jsp
- Legal Name Jw Lifescience Corporation
- Annual Revenue$178.53 M (USD)15.89as on Dec 31, 2025
- Net Profit$19.81 M (USD)-34.97as on Dec 31, 2025
- EBITDA$35.6 M (USD)-0.31as on Dec 31, 2025
- Employee Count328
Products & Services of JW Life Science
JW Life Science offers a comprehensive portfolio of products and services, including Intravenous Fluids and Research Services.
Intravenous solutions are produced for medical use in hospitals and healthcare settings
Research in life sciences and pharmaceuticals is conducted to support product development and innovation
IPO & Listings of JW Life Science
JW Life Science is a publicly listed company on the KRX with ticker symbol 234080 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Oct 2016
- Listed onKRX: 234080
- Listed entityJW LIFESCIENCE CORPORATION
- Exchange sectorHealth technology
- ISINKR7234080000
- Share price10,670.00 KRW (-0.28% on the day) · 2026-10-14
- Market capitalisation165,684,720,707.00 KRW
- Price to earnings6.3
- EPS (diluted, trailing year)1,680.36 KRW
- Dividend yield5.14%
- Volume (last session)18,729
Financials of JW Life Science
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 257.83B KRW | 28.61B KRW | 51.41B KRW |
| 2024 | 222.48B KRW | 43.99B KRW | 51.57B KRW |
| 2023 | 206.86B KRW | 28.14B KRW | 46.37B KRW |
| 2022 | 188.93B KRW | 14.96B KRW | 42.02B KRW |
| 2021 | 169.82B KRW | 12.91B KRW | 41.64B KRW |
Detailed financial statements for JW Life Science
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of JW Life Science
The website of JW Life Science (jw-lifescience.co.kr) receives about 5K visits a month.
- Monthly visits5K
Websites whose visitors overlap most with JW Life Science. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
metamedic.co.kr | metamedic.co.kr | 100% | #683,789 | β | |
medipana.com | medipana.com | 89% | #266,587 | β | |
| jw-pharma.co.kr | 78% | 83.5K | #347,046 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jw Life Science
Complete news archive for JW Life Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JW Life Science
JW Life Science was founded in 1994.
JW Life Science is headquartered in Seoul, South Korea.
JW Life Science has 328 employees.
Annual revenue of JW Life Science is $178.53M as on Dec 31, 2025.
JW Life Science was founded in 1994 in Seoul, South Korea. Intravenous solutions and a range of pharmaceutical products are manufactured by the company. Research and development activities in related pharmaceutical areas are conducted. Products are supplied to healthcare providers within the medical sector. Operations encompass production, research, and distribution across the pharmaceutical industry.
JW Life Science offers Intravenous Fluids and Research Services.
Yes, JW Life Science is publicly traded on KRX under the ticker symbol 234080.
JW Life Science operates through Jwμλͺ κ³Όν.
